Extra Corporeal Membrane Oxygenation (ecmo) System Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 575.01 Million |
| Market Size (2029) | USD 717.57 Million |
| CAGR (2024 - 2029) | 4.53 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players_System_Market_-_major_players.webp)
*Disclaimer: Major Players sorted in no particular order |
Extra Corporeal Membrane Oxygenation (ecmo) System Market Analysis
The Extra Corporeal Membrane Oxygenation System Market size is estimated at USD 575.01 million in 2024, and is expected to reach USD 717.57 million by 2029, at a CAGR of 4.53% during the forecast period (2024-2029).
The rising incidence of cardiovascular and respiratory diseases, coupled with technological advancements in ECMO and wider adoption of ECMO systems, is projected to drive the growth of the ECMO market during the forecast period.
The rising prevalence of respiratory and cardiovascular diseases, leading to inadequate oxygen supply, has driven a surge in demand for ECMO systems. The escalating burden of respiratory and cardiovascular diseases within the population has resulted in an increased demand for ECMO systems owing to the compromised oxygen delivery capacity in these conditions. For instance, according to the 2023 statistics published by the Australian Bureau of Statistics, COPD represented a significant proportion of Australia's overall disease burden in 2023, accounting for 3.6% of the total and a staggering 50% of the respiratory disease burden. During 2021-2022, 53,000 people aged 45 years and over were hospitalized based on a principal diagnosis of COPD (500 hospitalizations per 100,000 population). Thus, the high burden of COPD is expected to increase demand for ECMO systems and is likely to contribute significantly to the growth of the critical care equipment market over the forecast period.
The increasing availability of technologically advanced ECMO systems, driven by new product launches from ECMO companies, is expected to boost market growth in the coming years. For instance, in September 2023, an ECMO life support system for pediatric patients was launched at Burjeel Medical City (BMC) in Abu Dhabi. Similarly, in June 2024, Hemovent GmbH (Hemovent), an ECMO machine manufacturer, successfully rolled out its inaugural batch of MOBYBOX for commercial use in Europe, highlighting its remarkable portability in numerous intra- and inter-hospital transfers. Notably, MOBYBOX stands as the sole ECMO system that can secure certification under the Medical Device Regulation. The product has already hit the shelves in key markets such as Germany, the Netherlands, Italy, Greece, and Israel, with plans in motion to bolster its presence in the Middle East, the United States, and China.
Therefore, the extracorporeal membrane oxygenation market is poised for growth due to the increasing burden of cardiopulmonary diseases, rising adoption of ECMO systems, and frequent product launches. However, the high costs of ECMO procedures and associated risks may hinder market expansion.
Extra Corporeal Membrane Oxygenation (ecmo) System Market Trends
Respiratory Applications is Expected to Witness Significant Growth Over the Forecast Period
The respiratory segment is expected to witness significant growth in the extracorporeal membrane oxygenation devices market over the forecast period owing to factors such as the increasing burden of respiratory diseases among the population and growing company activities.
The rising prevalence and incidence of respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pneumonia, and lung cancer, among the population is the key factor driving the demand for respiratory support equipment such as ECMO machines. For instance, according to an article published in ERS Journal in August 2022, about 645.6 million people (454.4 million men and 191.2 million women) were expected to experience COPD by 2050, representing a 36% relative increase in global prevalence compared to the previous year. Similarly, according to the 2022 statistics published by the National Cancer Registry Programme, about 1,03,371 new lung cancer cases were reported in India in 2022, compared to 98,278 cases in the last year.
Furthermore, as per the study published in the ASAIO Journal in April 2022, it was observed that 83 adult patients had dynamic or hybrid ECMO configurations. Their primary diagnoses included cardiogenic shock (33.7%), cardiac arrest (6.0%), acute respiratory failure (39.8%), septic shock (9.6%), multiple trauma (3.6%), pulmonary hypertension (3.6%), and others (3.6%). The study concluded that dynamic or hybrid configurations for extracorporeal membrane oxygenation (ECMO) were needed when patient physiology or clinical conditions changed. Thus, the increasing adoption of membrane oxygenators during physiological or clinical condition changes is expected to boost the growth of the market studied over the forecast period.
Moreover, the rising product launches are also contributing to segment growth. For instance, in November 2022, LivaNova PLC received the US FDA's approval for its extracorporeal membrane oxygenation (ECMO). LifeSPARC is a next-generation advanced circulatory support (ACS) pump and controller system for cardiopulmonary bypass.
Therefore, the segment is expected to grow over the forecast period due to the factors above, such as the high burden of respiratory diseases, the growing adoption of extracorporeal life support systems, and increasing product launches.
North America is Expected to Record Significant Market Share Over the Forecast Period
North America is expected to hold a significant market share over the forecast period owing to its increasing prevalence of cardiovascular and respiratory diseases, advancements in ECMO technology, and increased adoption of advanced life support equipment.
The increasing burden of cardiovascular diseases and their associated risk factors, such as high blood pressure, obesity, type-2 diabetes, and poor dietary habits, increase the population's risk of developing chronic heart diseases, propelling market growth. For instance, as per 2022 statistics published by IDF, people living with diabetes in Canada are projected to reach 3.2 million by 2030 and 3.4 million by 2045. Therefore, high blood sugar caused by diabetes can damage the nerves that control the heart and blood vessels, leading to cardiovascular diseases like coronary artery disease and stroke, narrowing the arteries and necessitating coronary artery bypass procedures. These procedures call for life support systems, which are projected to enhance demand for ECMO machines and spur market expansion.
In addition, the increasing geriatric population is more prone to developing cardiopulmonary diseases, which may lead to surgeries. It increases the demand for ECMO systems and heart lung machines, which is expected to fuel market growth over the forecast period. For instance, as per 2022 statistics published by UNPF, about 17% and 19% of the US and Canadian population was 65 years and above in 2022.
Furthermore, as per 2022 statistics published by WHO, West Virginia recorded the highest smoking rate at 23.8%, followed by Kentucky at 23.6%, Louisiana at 21.9%, and Ohio at 20.8% in 2022. Thus, the high number of smokers in the region are at high risk of developing various lung diseases such as COPD. This, in turn, raises the demand for respiratory support equipment, propelling market growth.
Moreover, the growing number of new product launches and approvals is also contributing to the region's market growth. For instance, in July 2022, Inspira Technologies, an ECMO company, revealed its Liby System, an advanced form of extracorporeal life support ECMO device used to treat patients with life-threatening heart and lung failure. The system was expected to be submitted to the US Food and Drug Administration (FDA) for approval during the first half of 2023.
Therefore, the market studied is expected to grow over the forecast period due to the above factors, such as the high burden of cardiovascular and respiratory diseases and increasing product launches.
Extra Corporeal Membrane Oxygenation (ECMO) System Industry Overview
The extracorporeal membrane oxygenation market is fragmented and includes several key players. Some of the key ECMO companies and ECMO machine manufacturers in the market are LivaNova (Alung Technologies Inc.), Eurosets, Getinge AB, Medtronic PLC, Microport Scientific Corporation, Nipro Medical Corporation, Terumo Medical Corporation, Abbott Laboratories, and Fresenius Medical Care Company (Xenios AG).
Extra Corporeal Membrane Oxygenation (ecmo) System Market Leaders
-
LivaNova (Alung Technologies Inc.)
-
Eurosets
-
Getinge AB
-
Medtronic PLC
-
Terumo Medical Corporation
*Disclaimer: Major Players sorted in no particular order
Extra Corporeal Membrane Oxygenation (ecmo) System Market News
- May 2024: Hemovent GmbH (Hemovent) successfully rolled out its inaugural batch of MOBYBOX for commercial use in Europe, highlighting its remarkable portability in numerous intra- and inter-hospital transfers. Notably, MOBYBOX stands as the sole ECMO system that can secure certification under the Medical Device Regulation. The product has already hit the shelves in key markets such as Germany, the Netherlands, Italy, Greece, and Israel, with plans in motion to bolster its presence in the Middle East, the United States, and China.
- February 2023: Using rocket servo technology, China launched its own-developed extracorporeal membrane oxygenation (ECMO), also known as the artificial lung/heart system.
Extra Corporeal Membrane Oxygenation System Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumption and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Cardiovascular and Respiratory Diseases
4.2.2 Technological Advancements in ECMO Technology
4.2.3 Increased Adoption of ECMO Systems
4.3 Market Restraints
4.3.1 High Cost of ECMO Procedures
4.3.2 Risks Associated with ECMO System
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Modality
5.1.1 Veno-arterial (VA)
5.1.2 Veno-venous (VV)
5.1.3 Other Modalities
5.2 By Application
5.2.1 Respiratory Applications
5.2.2 Cardiac Applications
5.2.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
5.3 By Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 LivaNova (Alung Technologies Inc.)
6.1.2 Eurosets
6.1.3 Getinge AB
6.1.4 Medtronic PLC
6.1.5 Microport Scientific Corporation
6.1.6 Inspira Technologies
6.1.7 Terumo Medical Corporation
6.1.8 Abbott Laboratories
6.1.9 Fresenius Medical Care Company (Xenios AG)
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Extra Corporeal Membrane Oxygenation (ecmo) System Industry Segmentation
As per the scope of the report, extracorporeal membrane oxygenation (ECMO), also known as extracorporeal life support (ECLS), is an extracorporeal technique of providing prolonged cardiac and respiratory support to persons whose heart and lungs cannot provide an adequate amount of gas exchange or perfusion to sustain life. The technology for ECMO is primarily derived from cardiopulmonary bypass, which provides shorter-term support with arrested native circulation. The extracorporeal membrane oxygenation (ECMO) system market is segmented by modality, application, and geography. By modality, the market is segmented as veno-arterial (VA), veno-venous (VV), and other modalities. By application, the market is segmented into respiratory applications, cardiac applications, and extracorporeal cardiopulmonary resuscitation (CPR). By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD) for the above segments.
| By Modality | |
| Veno-arterial (VA) | |
| Veno-venous (VV) | |
| Other Modalities |
| By Application | |
| Respiratory Applications | |
| Cardiac Applications | |
| Extracorporeal Cardiopulmonary Resuscitation (ECPR) |
| By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Extra Corporeal Membrane Oxygenation System Market Research FAQs
How big is the Extra Corporeal Membrane Oxygenation System Market?
The Extra Corporeal Membrane Oxygenation System Market size is expected to reach USD 575.01 million in 2024 and grow at a CAGR of 4.53% to reach USD 717.57 million by 2029.
What is the current Extra Corporeal Membrane Oxygenation System Market size?
In 2024, the Extra Corporeal Membrane Oxygenation System Market size is expected to reach USD 575.01 million.
Who are the key players in Extra Corporeal Membrane Oxygenation System Market?
LivaNova (Alung Technologies Inc.), Eurosets, Getinge AB, Medtronic PLC and Terumo Medical Corporation are the major companies operating in the Extra Corporeal Membrane Oxygenation System Market.
Which is the fastest growing region in Extra Corporeal Membrane Oxygenation System Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Extra Corporeal Membrane Oxygenation System Market?
In 2024, the North America accounts for the largest market share in Extra Corporeal Membrane Oxygenation System Market.
What years does this Extra Corporeal Membrane Oxygenation System Market cover, and what was the market size in 2023?
In 2023, the Extra Corporeal Membrane Oxygenation System Market size was estimated at USD 548.96 million. The report covers the Extra Corporeal Membrane Oxygenation System Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Extra Corporeal Membrane Oxygenation System Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global Extra Corporeal Membrane Oxygenation (ECMO) System Industry Report
Statistics for the 2024 Extra Corporeal Membrane Oxygenation (ECMO) System market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Extra Corporeal Membrane Oxygenation (ECMO) System analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
Extra Corporeal Membrane Oxygenation (ECMO) System Market Report Snapshots
